Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

BACKGROUND: The aim of this study was to evaluate the usefulness of the presence of malignant pleural effusion (MPE) as a negative predictor of anti‐PD‐1 antibody efficacy. METHODS: A retrospective review of patients with advanced or recurrent non‐small cell lung cancer treated with an anti‐PD‐1 ant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449236/
https://ncbi.nlm.nih.gov/pubmed/30762312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados